Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor.
Saved in:
| Title: | Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor. |
|---|---|
| Authors: | Lockbaum GJ; Accent Therapeutics, Lexington, MA, 02421, USA., Lynes MM; Accent Therapeutics, Lexington, MA, 02421, USA. mlynes@accenttx.com., Shen SA; Accent Therapeutics, Lexington, MA, 02421, USA., Liu J; Accent Therapeutics, Lexington, MA, 02421, USA., Holt N; Accent Therapeutics, Lexington, MA, 02421, USA., Nayak SP; Accent Therapeutics, Lexington, MA, 02421, USA., Knockenhauer KE; Accent Therapeutics, Lexington, MA, 02421, USA., Yao S; Accent Therapeutics, Lexington, MA, 02421, USA., Sickmier EA; Accent Therapeutics, Lexington, MA, 02421, USA., Raman A; Accent Therapeutics, Lexington, MA, 02421, USA., Wu J; Accent Therapeutics, Lexington, MA, 02421, USA., Case A; Accent Therapeutics, Lexington, MA, 02421, USA., Shehaj L; Accent Therapeutics, Lexington, MA, 02421, USA., Buker SM; Accent Therapeutics, Lexington, MA, 02421, USA., Grigoriu S; Accent Therapeutics, Lexington, MA, 02421, USA., Ribich S; Accent Therapeutics, Lexington, MA, 02421, USA., Blakemore SJ; Accent Therapeutics, Lexington, MA, 02421, USA., Sparling BA; Accent Therapeutics, Lexington, MA, 02421, USA., Duncan KW; Accent Therapeutics, Lexington, MA, 02421, USA., Copeland RA; Accent Therapeutics, Lexington, MA, 02421, USA., Silver SJ; Accent Therapeutics, Lexington, MA, 02421, USA., Boriack-Sjodin PA; Accent Therapeutics, Lexington, MA, 02421, USA. |
| Source: | Communications biology [Commun Biol] 2025 Apr 09; Vol. 8 (1), pp. 589. Date of Electronic Publication: 2025 Apr 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40205031 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lockbaum+GJ%22">Lockbaum GJ</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Lynes+MM%22">Lynes MM</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA. mlynes@accenttx.com.<br /><searchLink fieldCode="AU" term="%22Shen+SA%22">Shen SA</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Holt+N%22">Holt N</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Nayak+SP%22">Nayak SP</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Knockenhauer+KE%22">Knockenhauer KE</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Yao+S%22">Yao S</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Sickmier+EA%22">Sickmier EA</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Raman+A%22">Raman A</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Case+A%22">Case A</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Shehaj+L%22">Shehaj L</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Buker+SM%22">Buker SM</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Grigoriu+S%22">Grigoriu S</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Ribich+S%22">Ribich S</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Blakemore+SJ%22">Blakemore SJ</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Sparling+BA%22">Sparling BA</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Duncan+KW%22">Duncan KW</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Copeland+RA%22">Copeland RA</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Silver+SJ%22">Silver SJ</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Boriack-Sjodin+PA%22">Boriack-Sjodin PA</searchLink>; Accent Therapeutics, Lexington, MA, 02421, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101719179%22">Communications biology</searchLink> [Commun Biol] 2025 Apr 09; Vol. 8 (1), pp. 589. <i>Date of Electronic Publication: </i>2025 Apr 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+UK%22">Nature Publishing Group UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101719179 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2399-3642 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223993642%22">23993642 </searchLink><i>NLM ISO Abbreviation: </i>Commun Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40205031 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42003-025-08005-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 589 Titles: – TitleFull: Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lockbaum GJ – PersonEntity: Name: NameFull: Lynes MM – PersonEntity: Name: NameFull: Shen SA – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Holt N – PersonEntity: Name: NameFull: Nayak SP – PersonEntity: Name: NameFull: Knockenhauer KE – PersonEntity: Name: NameFull: Yao S – PersonEntity: Name: NameFull: Sickmier EA – PersonEntity: Name: NameFull: Raman A – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Case A – PersonEntity: Name: NameFull: Shehaj L – PersonEntity: Name: NameFull: Buker SM – PersonEntity: Name: NameFull: Grigoriu S – PersonEntity: Name: NameFull: Ribich S – PersonEntity: Name: NameFull: Blakemore SJ – PersonEntity: Name: NameFull: Sparling BA – PersonEntity: Name: NameFull: Duncan KW – PersonEntity: Name: NameFull: Copeland RA – PersonEntity: Name: NameFull: Silver SJ – PersonEntity: Name: NameFull: Boriack-Sjodin PA IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 04 Text: 2025 Apr 09 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2399-3642 Numbering: – Type: volume Value: 8 – Type: issue Value: 1 Titles: – TitleFull: Communications biology Type: main |
| ResultId | 1 |